Kodiak Sciences (KOD) Other Working Capital Changes (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Other Working Capital Changes came in at -$3.2 million in Q1 2026, down 17.81% YoY from -$3.9 million in Q1 2025, and down 5.53% on a QoQ basis from -$3.0 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 8 years of Other Working Capital Changes data on file, last reported at -$3.2 million in Q1 2026.
- Quarterly Other Working Capital Changes fell 17.81% year-over-year to -$3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.6 million (down 9.04% YoY) and the FY2025 annual result came in at -$11.2 million, up 0.76% from the prior year.
- Other Working Capital Changes eased to -$3.2 million in Q1 2026, from -$3.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $7.2 million in Q1 2022 to a low of -$17.4 million in Q2 2022.
- A 5-year average of -$403000.0 and a median of -$44000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 7403.09% in 2023, down 340.0% in 2023.
- Tracing KOD's Other Working Capital Changes over 5 years: stood at -$97000.0 in 2022, then jumped by 7403.09% to $7.1 million in 2023, then sank by 143.62% to -$3.1 million in 2024, then rose by 2.23% to -$3.0 million in 2025, then dropped by 5.53% to -$3.2 million in 2026.
- The last three Other Working Capital Changes figures came in at -$3.2 million (Q1 2026), -$3.0 million (Q4 2025), and -$3.0 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.24 Mn |
| Jun 30, 2026 | -3.24 Mn |
| Mar 31, 2026 | -3.19 Mn |
| Mar 31, 2026 | -3.19 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -3.01 Mn |
| Sep 30, 2025 | -3.01 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Jun 30, 2025 | -2.43 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Sep 30, 2024 | -2.32 Mn |
| Sep 30, 2024 | -2.32 Mn |
| Jun 30, 2024 | -2.56 Mn |
| Jun 30, 2024 | -2.56 Mn |
| Mar 31, 2024 | -3.28 Mn |
| Mar 31, 2024 | -3.28 Mn |